Bank of America’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-44,317
Closed -$406K 7594
2021
Q2
$406K Buy
44,317
+10,342
+30% +$94.7K ﹤0.01% 4856
2021
Q1
$169K Buy
33,975
+16,126
+90% +$80.2K ﹤0.01% 5481
2020
Q4
$77K Buy
17,849
+8,224
+85% +$35.5K ﹤0.01% 5379
2020
Q3
$41K Sell
9,625
-6,804
-41% -$29K ﹤0.01% 5439
2020
Q2
$74K Buy
16,429
+2,104
+15% +$9.48K ﹤0.01% 5242
2020
Q1
$57K Sell
14,325
-3,041
-18% -$12.1K ﹤0.01% 5228
2019
Q4
$147K Buy
17,366
+1,217
+8% +$10.3K ﹤0.01% 5009
2019
Q3
$111K Buy
16,149
+2,206
+16% +$15.2K ﹤0.01% 5188
2019
Q2
$115K Sell
13,943
-31
-0.2% -$256 ﹤0.01% 5175
2019
Q1
$128K Sell
13,974
-31,553
-69% -$289K ﹤0.01% 5003
2018
Q4
$498K Sell
45,527
-12,243
-21% -$134K ﹤0.01% 4270
2018
Q3
$806K Buy
57,770
+28,310
+96% +$395K ﹤0.01% 3982
2018
Q2
$314K Buy
29,460
+6,860
+30% +$73.1K ﹤0.01% 4481
2018
Q1
$195K Sell
22,600
-1,560
-6% -$13.5K ﹤0.01% 4684
2017
Q4
$228K Buy
24,160
+2,663
+12% +$25.1K ﹤0.01% 4584
2017
Q3
$168K Buy
21,497
+1,182
+6% +$9.24K ﹤0.01% 4699
2017
Q2
$175K Sell
20,315
-72,158
-78% -$622K ﹤0.01% 4646
2017
Q1
$652K Sell
92,473
-10,001
-10% -$70.5K ﹤0.01% 4057
2016
Q4
$436K Sell
102,474
-847
-0.8% -$3.6K ﹤0.01% 4185
2016
Q3
$515K Sell
103,321
-688
-0.7% -$3.43K ﹤0.01% 3928
2016
Q2
$368K Buy
104,009
+3,532
+4% +$12.5K ﹤0.01% 4125
2016
Q1
$347K Buy
100,477
+20,701
+26% +$71.5K ﹤0.01% 4085
2015
Q4
$271K Buy
79,776
+3,761
+5% +$12.8K ﹤0.01% 4273
2015
Q3
$396K Sell
76,015
-304
-0.4% -$1.58K ﹤0.01% 4055
2015
Q2
$520K Buy
76,319
+275
+0.4% +$1.87K ﹤0.01% 3781
2015
Q1
$542K Buy
76,044
+5,529
+8% +$39.4K ﹤0.01% 3417
2014
Q4
$525K Buy
70,515
+57,615
+447% +$429K ﹤0.01% 3557
2014
Q3
$119K Buy
12,900
+11,587
+882% +$107K ﹤0.01% 4393
2014
Q2
$24K Buy
+1,313
New +$24K ﹤0.01% 5319